Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. 2invest AG
  6. Summary
    2INV   DE000A3H3L44

2INVEST AG

(2INV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
12.8(c) 12.76(c) 12.7(c) 12.82(c) 12.68(c) Last
6 560 1 244 1 257 1 833 4 470 Volume
0.00% -0.31% -0.47% +0.94% -1.09% Change
More quotes
Estimated financial data (e)
Sales 2021 0,23 M 0,27 M 0,27 M
Net income 2021 -3,72 M -4,36 M -4,36 M
Net Debt 2021 10,7 M 12,5 M 12,5 M
P/E ratio 2021 -41,3x
Yield 2021 -
Sales 2022 0,35 M 0,41 M 0,41 M
Net income 2022 -4,07 M -4,77 M -4,77 M
Net Debt 2022 5,93 M 6,95 M 6,95 M
P/E ratio 2022 -38,2x
Yield 2022 -
Capitalization 72,9 M 85,6 M 85,4 M
EV / Sales 2021 359x
EV / Sales 2022 226x
Nbr of Employees 2
Free-Float 41,5%
More Financials
Company
2Invest AG, formerly 4Basebio AG, is a Germany-based investment company. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad. 
More about the company
Ratings of 2invest AG
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about 2INVEST AG
07/132INVEST : Preliminary half-year results as of 30.06.2021
PU
06/302INVEST : Release according to Article 40, Section 1 of the WpHG
PU
06/282INVEST : Report of the Supervisory Board of 2invest AG for the financial year f..
PU
06/142INVEST : Release according to Article 40, Section 1 of the WpHG
PU
05/312INVEST : Release according to Article 40, Section 1 of the WpHG
PU
05/142INVEST : Release according to Article 40, Section 1 of the WpHG
PU
05/114BASEBIO : Quarterly statement as at 31 March 2021 published
PU
04/284BASEBIO : Application for change from Prime Standard to General Standard
PU
03/014BASEBIO AG : REVERSE SPLIT: 1 of 9
FA
02/224BASEBIO : Implementation of the reverse stock split of 4basebio AG
PU
02/184BASEBIO : KROMI takeover offer will not be pursued further
PU
02/104BASEBIO : Preliminary annual result as of 31.12.2020
PU
02/104Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2..
CI
02/034BASEBIO AG : Spin off
FA
01/294BASEBIO : Further processing of the spin-off
PU
More news
News in other languages on 2INVEST AG
09/15EPIGENOMICS AG : Veröffentlichung gemäß ž 40 Abs. 1 WpHG mit dem Ziel der europa..
09/13THETA GOLD MINES LIMITED : Theta Gold Mines Limited: Schreiben des Chairman an d..
07/232INVEST : Voting results of the AGM 2021
07/132INVEST : Vorläufiges Halbjahresergebnis zum 30.06.2021
07/13PTA-ADHOC : 2invest AG: Vorläufiges Halbjahresergebnis zum 30.06.2021
More news
Chart 2INVEST AG
Duration : Period :
2invest AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 2INVEST AG
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 12,68 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
David John Roth Chief Financial Officer
Joseph Manuel Fernßndez Chairman-Supervisory Board
Sebastian Paul VP-Finance & Administration
Maria del Pilar de la Huerta Martinez Member-Supervisory Board
Timothy Paul McCarthy Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
2INVEST AG596.70%86
INVESTOR AB (PUBL)33.05%69 913
CK HUTCHISON HOLDINGS LIMITED-2.96%25 894
HAL TRUST32.13%15 487
AB INDUSTRIVÄRDEN (PUBL)7.73%14 531
LIFCO AB (PUBL)62.86%13 413